The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with those of heparin with or without routine administration of a glycoprotein IIb/IIIa inhibitor (GPI) in patients with acute coronary syndrome (ACS).

Navarese, E. P., Schulze, V., Andreotti, F., Kowalewski, M., Kołodziejczak, M., Kandzari, D., Rassaf, T., Gorny, B., Brockmeyer, M., Meyer, C., Berti, S., Kubica, J., Kelm, M., Valgimigli, M., Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome, <<JACC: CARDIOVASCULAR INTERVENTIONS>>, 2015; 8 (Gennaio): 201-213. [doi:10.1016/j.jcin.2014.10.003] [http://hdl.handle.net/10807/66058]

Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome

Navarese, Eliano Pio;Andreotti, Felicita;
2015

Abstract

The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with those of heparin with or without routine administration of a glycoprotein IIb/IIIa inhibitor (GPI) in patients with acute coronary syndrome (ACS).
Inglese
Navarese, E. P., Schulze, V., Andreotti, F., Kowalewski, M., Kołodziejczak, M., Kandzari, D., Rassaf, T., Gorny, B., Brockmeyer, M., Meyer, C., Berti, S., Kubica, J., Kelm, M., Valgimigli, M., Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome, <<JACC: CARDIOVASCULAR INTERVENTIONS>>, 2015; 8 (Gennaio): 201-213. [doi:10.1016/j.jcin.2014.10.003] [http://hdl.handle.net/10807/66058]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/66058
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 65
social impact